SHERRELL APUGO
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family WASHINGTON, DC NPI 1639726409
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family DC Acerta Pharma LLC All categories
General Payments — all program years on this page
$1,520.41
- Category: General Payments
- Program years: PY2021–2022
- Record count: 12
- As of (CMS publication): 2026-01-23
Latest program year (PY2022): $1,093.05 across 6 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2022) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $600.00 | 1 |
| Travel and Lodging | $317.57 | 2 |
| Food and Beverage | $175.48 | 3 |
By paying entity
Latest program year (PY2022) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $600.00 | 1 |
| Abbott Laboratories | $467.98 | 4 |
| Alnylam Pharmaceuticals Inc. | $25.07 | 1 |
By program year
Records — PY2022 (6)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 915635311 | AstraZeneca Pharmaceuticals LP | $600.00 | 12/22/2022 | Consulting Fee | Undisputed | 01/23/2026 | View at CMS |
| 920101077 | Abbott Laboratories | $94.86 | 05/02/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 920646561 | Abbott Laboratories | $9.67 | 03/26/2022 | Travel and Lodging | Undisputed | 01/23/2026 | View at CMS |
| 920646563 | Abbott Laboratories | $307.90 | 05/23/2022 | Travel and Lodging | Undisputed | 01/23/2026 | View at CMS |
| 921914835 | Abbott Laboratories | $55.55 | 05/02/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 926091603 | Alnylam Pharmaceuticals Inc. | $25.07 | 05/11/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.